Synthesis method and application of mesoporous bioglass material

The mesoporous bioglass material was prepared by the template method combined with the sol-gel method, which solved the problems of unstable bonding of bioglass materials in bodily fluid environments and insufficient drug sustained release performance, and achieved the preparation of mesoporous structures and had good bones Repair and drug sustained release performance, suitable for the treatment of skull defects.

CN119059738AInactive Publication Date: 2024-12-03THE SECOND AFFILIATED HOSPITAL OF NAVAL MEDICAL UNIVERSITY PLA

Patent Information

Application Number
CN202411554686.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-11-04
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The hydroxyapatite-like layer formed by the surface interface of existing bioglass materials in the bodily fluid environment is unstable in bonding with surrounding bone tissue, lacks drug loading and sustained release properties, and needs to be used in the environment of infectious bone defects or osteomyelitis. Antibiotics have problems with inconvenience in use.

Method used

Mesoporous bioglass materials were prepared by template method combined with sol-gel method, and cetyl trimethylammonium bromide was used as soft template agent, ethyl orthosilicate and triethyl phosphate were used as silicon and phosphorus sources, and tetrahydrate was used as water. As a calcium source, mesoporous bioglass microspheres with pore sizes of 3-5 nm were prepared, with highly ordered mesoporous structures for bone repair and drug sustained release.

Benefits of technology

It realizes the uniformity of mesoporous bioglass materials and the uniformity of pore structure, improves specific surface area and biological activity, has good drug sustained release performance and bone generation promotion ability, is suitable for bone repair of skull defects, and can regulate pore size Ranges are at the nano-micron level, reducing the complexity of drug use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119059738A_ABST
    Figure CN119059738A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of materials, and discloses a synthesis method and application of a mesoporous bioglass material, a reaction is carried out in a mixed system of absolute ethyl alcohol, deionized water and ammonia water, hexadecyl trimethyl ammonium bromide is used as a soft template agent, tetraethoxysilane is used as a silicon source, triethyl phosphate is used as a phosphorus source, and the mesoporous bioglass material is prepared through a hydrothermal method. Compared with the prior art, the mesoporous bioglass material has the advancement that the mesoporous bioglass material is good in uniformity, rich and uniform in pore structure, nanoscale and excellent in specific surface area, and meanwhile, the material can effectively promote osteogenesis in vivo, so that the bioglass material can be used for treating osteoporosis. The material is expected to be developed into a novel artificial bone material. And the nano-micron pore-diameter-adjustable porous material has excellent drug sustained-release performance, and the pore diameter range can be adjusted and controlled at the nano-micron level according to drug selection in the actual use process.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of materials, and in particular to a synthesis method and application of a mesoporous bioglass material. Background Art

[0002] Bone transplant materials are widely used in orthopedics, dentistry, medical aesthetics and other fields. Autologous bone or allogeneic bone materials are the gold standard for clinical application, but they have shortcomings such as limited sources and risks of disease transmission. Artificial bone has been the focus of bone transplant material development in recent years.

[0003] Compared with traditional bioceramic artificial bones, bioglass artificial bones have good biocompatibility and osteoconductivity. In the body fluid environment, the surface interface of bioglass can form a hydroxyapatite-like layer, forming a stable bond with the surrounding bone tissue. At the same time, it releases Ca, Si and other ions to exert good biological activity, so it has broad development prospects. In 1969, the first generation of 45S5 bioglass was successfully prepared. It was prepared by melting method, with low purity, uneven particle size, difficult to accurately control the components, and dense and non-porous surface. The second generation of bioglass was prepared by sol-gel method, which to a certain extent overcame the shortcomings of the previous generation of products, and has greatly improved in purity, particle size, component control, etc., and has a porous structure, which is conducive to the adsorption and response of proteins or cells, and significantly improves biological activity. The new generation of bioglass adopts a template method combined with a sol-gel preparation process, and can be designed into a highly ordered mesoporous structure as needed. On the one hand, it continues and enhances the advantages of the second-generation bioglass. On the other hand, the mesoporous structure gives it excellent performance in drug loading and sustained release, which has attracted widespread attention. For example, compared with autologous bone, artificial bone lacks bone inductivity and needs to be used in combination with bone morphogenetic protein, stem cells, etc. to improve its bone formation ability. In specific environments such as infectious bone defects and osteomyelitis, artificial bone often needs to be used in combination with antibiotics. Mesoporous bioglass artificial bone not only plays the role of filling scaffolds, but also can be used as an excellent drug sustained-release carrier, which has significant advantages.

[0004] It is worth mentioning that in the past, the activity of bioglass was usually evaluated by the formation of hydroxyapatite-like substances under simulated body fluids, and the results were not completely consistent with the results of cell and animal osteogenesis verification. In summary, the present invention aims to provide a preparation method and performance evaluation of mesoporous bioglass. Compared with the prior art, its advanced features are as follows: good uniformity, rich and uniform pore structure, nanoscale, excellent specific surface area, and the material effectively promotes bone formation in vivo, and is expected to be developed into a new type of artificial bone material. It has excellent drug sustained-release performance, and according to the drug selection in actual use, the pore size range can be adjusted at the nanometer-micrometer level. Summary of the invention

[0005] 1. Technical issues to be resolved In view of the deficiencies in the prior art, the present invention provides a synthesis method and application of a mesoporous bioglass material.

[0006] (II) Technical solution To achieve the above-mentioned purpose, the present invention provides the following technical solution: a mesoporous bioglass material, the morphology of which is microsphere-shaped, string-shaped or cluster-shaped, the diameter of a single microsphere is 2-4 μm, the specific surface area is 465 m2 / g, the mesoporous structure on the surface of the microsphere is highly ordered, the pore diameter is 3-5 nm, and most of the pore diameters are 3.6 nm.

[0007] Preferably, A method for synthesizing a mesoporous bioglass material comprises the following steps: reacting in a mixed system of anhydrous ethanol, deionized water and ammonia water, using hexadecyltrimethylammonium bromide as a soft template, using ethyl orthosilicate as a silicon source, using ethyl orthosilicate as a silicon source, using triethyl phosphate as a phosphorus source, and using calcium nitrate tetrahydrate as a calcium source, and obtaining the mesoporous bioglass material through a template method combined with a sol-gel preparation process.

[0008] Preferably, The following steps are involved: (1) Mesoporous hollow bioglass microspheres were prepared using hexadecyltrimethylammonium bromide as a soft template, tetraethyl orthosilicate as a silicon source, triethyl phosphate as a phosphorus source, and calcium nitrate tetrahydrate as a calcium source, wherein the molar ratios of the template, silicon source, phosphorus source, and calcium source were (9-30):60:4:12, respectively; (2) Dissolve 2 g of hexadecyltrimethylammonium bromide in a mixed solution of 80 mL of anhydrous ethanol and 160 mL of deionized water at room temperature, stir until clear, add 3.6 mL of ammonia water, stir magnetically for 2 h, then add 2.8 g of ethyl orthosilicate, stir for 1 h, and obtain a solution with a white precipitate. (3) Add 0.4 g of triethyl phosphate, stir for 1 h until completely mixed, then add 1.2 g of calcium nitrate tetrahydrate, continue stirring for 12 h to obtain a white suspension, then filter it, wash with anhydrous ethanol and deionized water, repeat the washing 2-3 times, and dry it at 60 ° C for 24 h; (4) The obtained white powder was placed in a Muffle furnace and calcined at 550°C for 6 h at a heating rate of 2°C / min to completely remove the template, thereby obtaining a mesoporous bioglass material.

[0009] Preferably, The hexadecyltrimethylammonium bromide is a quaternary ammonium salt organic compound, which is obtained by a quaternization method, using hexadecanol and hydrobromic acid as raw materials, firstly undergoing a bromination reaction in the presence of a sulfuric acid catalyst to generate hexadecane bromide, and then undergoing a quaternization reaction with trimethylamine; Micelle formation in solution provides a template for the formation of mesoporous structure.

[0010] Preferably, The tetraethyl orthosilicate can be prepared by reacting silicon tetrachloride with ethanol, and is a common precursor for preparing silicon-based materials, and its hydrolysis product can form a silicon skeleton; The calcium nitrate tetrahydrate is prepared by mixing an appropriate amount of nitric acid with a calcium hydroxide solution to generate an aqueous solution of calcium nitrate, and obtaining calcium nitrate tetrahydrate crystals from the aqueous solution by evaporation and crystallization, thereby providing calcium elements for bioglass and improving its biological activity and bone bonding ability.

[0011] Preferably, Ammonia water is added during the preparation process to adjust the pH value of the solution and maintain alkalinity to promote the hydrolysis and polycondensation reactions of the silicon source and the phosphorus source.

[0012] Preferably, An application of a mesoporous bioglass material, characterized in that the mesoporous bioglass material promotes bone mass recovery and collagen deposition, and is used for bone repair in skull defects.

[0013] Preferably, the bone repair material is made of a single material of mesoporous bioglass material or a related composite material using the mesoporous bioglass material as a carrier or a filling scaffold.

[0014] (III) Beneficial effects Compared with the prior art, the present invention provides a synthesis method and application of a mesoporous bioglass material, which has the following beneficial effects: 1. Compared with the existing technology, the synthesis method and application of the mesoporous bioglass material are advanced in that it has good uniformity, rich and uniform pore structure, nanometer-level, and excellent specific surface area. At the same time, the material effectively promotes bone formation in the body and is expected to be developed into a new type of artificial bone material. It has excellent drug sustained-release performance, and the pore size range can be adjusted at the nanometer-micrometer level according to the drug selection in the actual use process.

[0015] 2. The synthesis method and application of the mesoporous bioglass material. The bioglass material prepared by the template method combined with the sol-gel method has a regular mesoporous structure, adjustable pore size, and uniform distribution. This mesoporous structure helps to increase the specific surface area and porosity of the material, improve its adsorption performance and biological activity. The bioglass material is mainly composed of oxides such as SiO2, CaO and P2O5, and the proportion can be adjusted as needed. These oxide components give the bioglass material good biocompatibility and bone bonding ability. It can be prepared using common chemical reagents and simple experimental equipment, and has the advantages of low cost and easy operation.

[0016] 3. Synthesis method and application of the mesoporous bioglass material. The mesoporous bioglass material has broad application prospects in the biomedical field and can be used as bone repair materials, drug carriers, and gene transfection carriers. Due to its good biocompatibility and bone binding ability, the mesoporous bioglass material has significant advantages in promoting bone tissue regeneration and repair. At the same time, its mesoporous structure also provides convenient conditions for drug loading and release, which helps to improve the therapeutic effect and safety of drugs. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 A low-magnification scanning electron microscope image of the mesoporous bioglass material prepared in Example 1 of the present invention.

[0018] Figure 2 A high-magnification scanning electron microscope image of the mesoporous bioglass material prepared in Example 1 of the present invention.

[0019] Figure 3 Nitrogen adsorption-desorption curve of the mesoporous bioglass material prepared in Example 1 of the present invention.

[0020] Figure 4 Pore ​​size distribution diagram of the mesoporous bioglass material prepared in Example 1 of the present invention.

[0021] Figure 5 Micro-CT scanning results of in vivo osteogenesis test of the mesoporous bioglass material prepared in Example 1 of the present invention.

[0022] Figure 6 Statistical results of micro-CT data of in vivo osteogenesis of the mesoporous bioglass material prepared in Example 1 of the present invention.

[0023] Figure 7 HE staining results of in vivo osteogenesis of the mesoporous bioglass material prepared in Example 1 of the present invention.

[0024] Figure 8 Masson staining results of in vivo osteogenesis of the mesoporous bioglass material prepared in Example 1 of the present invention. DETAILED DESCRIPTION

[0025] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0026] See also Figure 1- Figure 8, a mesoporous bioglass material, the morphology of the material is microspheres, in the form of strings or clusters, the diameter of a single microsphere is 2-4 μm, the specific surface area is 465 m2 / g, the mesoporous structure on the surface of the microsphere is highly ordered, the pore size is 3-5 nm, and most of the pores are 3.6 nm.

[0027] The present invention further provides a specific preparation method of the mesoporous bioglass material.

[0028] (1) Mesoporous hollow bioglass microspheres were prepared using hexadecyltrimethylammonium bromide as a soft template, tetraethyl orthosilicate as a silicon source, triethyl phosphate as a phosphorus source, and calcium nitrate tetrahydrate as a calcium source. The molar ratios of the template, silicon source, phosphorus source, and calcium source were (9-30):60:4:12, respectively.

[0029] The hexadecyltrimethylammonium bromide is a quaternary ammonium salt organic compound, which is obtained by a quaternization method, using hexadecanol and hydrobromic acid as raw materials, firstly undergoing a bromination reaction in the presence of a sulfuric acid catalyst to generate hexadecane bromide, and then undergoing a quaternization reaction with trimethylamine; Form micelles in solution, providing a template for the formation of mesoporous structures; The tetraethyl orthosilicate can be prepared by reacting silicon tetrachloride with ethanol, and is a common precursor for preparing silicon-based materials, and its hydrolysis product can form a silicon skeleton; The calcium nitrate tetrahydrate is prepared by mixing an appropriate amount of nitric acid with a calcium hydroxide solution to generate an aqueous solution of calcium nitrate, and obtaining calcium nitrate tetrahydrate crystals from the aqueous solution by evaporation and crystallization, thereby providing calcium elements for bioglass and improving its biological activity and bone bonding ability.

[0030] (2) Dissolve 2 g of hexadecyltrimethylammonium bromide in a mixed solution of 80 mL of anhydrous ethanol and 160 mL of deionized water at room temperature, stir until clear, add 3.6 mL of ammonia water, stir magnetically for 2 h, then add 2.8 g of ethyl orthosilicate, stir for 1 h, and obtain a solution with a white precipitate. Ammonia water is added during the preparation process to adjust the pH value of the solution and maintain alkalinity to promote the hydrolysis and polycondensation reactions of the silicon source and the phosphorus source.

[0031] (3) Add 0.4 g of triethyl phosphate, stir for 1 h until completely mixed, then add 1.2 g of calcium nitrate tetrahydrate, continue stirring for 12 h, and obtain a white suspension. Then, filter it, wash it with anhydrous ethanol and deionized water, repeat the washing 2-3 times, and dry it at 60 ° C for 24 h.

[0032] (4) The obtained white powder was placed in a Muffle furnace and calcined at 550°C for 6 h at a heating rate of 2°C / min to completely remove the template, thereby obtaining a mesoporous bioglass material.

[0033] The mesoporous bioglass material promotes bone mass recovery and collagen deposition and is used for bone repair in skull defects.

[0034] The bone repair material is made of a single material of mesoporous bioglass material or a related composite material using the mesoporous bioglass material as a carrier or a filling scaffold.

[0035] Example 1: Preparation of mesoporous bioglass materials Mesoporous hollow bioglass microspheres were prepared using hexadecyl trimethyl ammonium bromide as a soft template, tetraethyl orthosilicate as a silicon source, triethyl phosphate as a phosphorus source, and calcium nitrate tetrahydrate as a calcium source, wherein the molar ratios of the template, silicon source, phosphorus source, and calcium source were (9-30)∶60∶4∶12, respectively. 2 g of hexadecyl trimethyl ammonium bromide was dissolved in a mixed solution of 80 mL of anhydrous ethanol and 160 mL of deionized water at room temperature, stirred evenly until clarified, and then 3.6 mL of ammonia water was added. After magnetic stirring for 2 h, 2.8 g of tetraethyl orthosilicate was added and stirred for 1 h to obtain a solution with a white precipitate. Then, 0.4 g of triethyl phosphate was added, stirred for 1 h until completely mixed, and then 1.2 g of calcium nitrate tetrahydrate was added and stirred for 12 h to obtain a white suspension. Then, it was filtered, washed with anhydrous ethanol and deionized water, and washed 2-3 times, and dried at 60 ° C for 24 h. The obtained white powder was placed in a Muffle furnace and calcined at 550°C for 6 hours at a heating rate of 2°C / min to completely remove the template agent, thereby obtaining a mesoporous bioglass material.

[0036] Example 2: Characterization of mesoporous bioglass materials The material was imaged using a scanning electron microscope to detect the morphology of the material and its surface mesopore distribution. The material was dehydrated and dried, and after vacuuming for 10 h, the N2 adsorption-desorption isotherm and surface mesopore distribution of the material were measured at 77.35 K using a nitrogen adsorption desorption instrument. The specific surface area and pore size distribution of the material were calculated using the Brunauer-Emmett-Teller (BET) and Barrett Joyner-Halenda (BJH) methods, respectively.

[0037] from Figure 1 It can be seen that the mesoporous bioglass material is a uniform microsphere with a diameter of 2-4μm under a low-power scanning electron microscope. Some microspheres are aggregated together in a string or cluster shape. The diameter of some microspheres is larger, about 5μm. Under a high-power microscope, it can be seen that the surface of the material is relatively rough, with a rich pore structure and a relatively uniform distribution; the pore diameter is small, at the nanoscale ( Figure 2 ).

[0038] like Figure 3As shown in the figure, the adsorption amount of the mesoporous bioglass increases sharply in the initial stage of adsorption (0-0.1P / P0), and increases slowly with the increase of relative pressure. When the relative pressure reaches 0.7P / P0, a second incremental zone appears, which is a typical type I adsorption isotherm. Its hysteresis loop has no obvious saturated adsorption platform and belongs to the H4 type hysteresis loop, indicating that the material has a slit-like pore structure. The specific surface area of ​​the mesoporous material is calculated to be 465 m2 / g.

[0039] The pore size distribution diagram shows that the pore size of mesoporous bioglass is basically distributed in the range of 3-5 nm, which is a typical mesoporous material. Its pore size is mainly 3.6 nm ( Figure 4 ).

[0040] Example 3: Evaluation of in vivo osteogenic activity of mesoporous bioglass The rat skull defect model was used to evaluate the osteogenic effect of mesoporous bioglass materials. 8-week-old male SD rats were selected, and a circular defect with a diameter of 5 mm was prepared in the middle of the rat parietal bone. Material group (n=5): about 10 mg of mesoporous bioglass was filled in the defect site, the surface was covered with collagen membrane, and then the defect was sutured in layers. Blank control group (n=5): control rats were not filled with material, the surface was covered with collagen membrane, and then the defect was sutured in layers. The rats were killed after 4 weeks, and the samples were taken for micro-CT scanning and analysis to detect the bone growth level. At the same time, the main bone parameters of each group were analyzed: bone mineral density (BMD), bone volume fraction (BV / TV), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp), and trabecular number (Tb.N). The tissues were embedded in paraffin and sectioned, and the level of collagen formation in the bone was detected by HE staining and masson staining.

[0041] Micro-CT results showed that compared with the blank control group, after implantation of mesoporous bioglass materials, the bone tissue in the skull defect area of ​​rats recovered, and obvious high-density images were observed ( Figure 5 ); The bone mineral density (BMD) and trabecular thickness (Tb.Th) in the mesoporous bioglass material group increased significantly, with statistically significant differences. In addition, the bone volume fraction (BV / TV) and trabecular separation (Tb.Sp) increased ( Figure 6 ), indicating that mesoporous bioglass can promote bone formation.

[0042] HE staining results showed that some inflammatory cell infiltration was observed in the mesoporous bioglass material 4 weeks after implantation, but the tissue thickness increased compared with the blank control group ( Figure 7 Masson staining results showed that compared with the blank control group, a large amount of new collagen tissue grew in the defect site 4 weeks after implantation of mesoporous bioglass material ( Figure 8 ).

[0043] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A mesoporous bioglass material, characterized in that: The material has a microsphere shape in the form of strings or clusters, a single microsphere has a diameter of 2-4 μm, a specific surface area of ​​465 m2 / g, and a highly ordered mesoporous structure on the surface of the microsphere, with a pore size of 3-5 nm.

2. The method for synthesizing a mesoporous bioglass material according to claim 1, characterized in that: The reaction was carried out in a mixed system of anhydrous ethanol, deionized water and ammonia water, with hexadecyltrimethylammonium bromide as a soft template, tetraethyl orthosilicate as a silicon source, triethyl phosphate as a phosphorus source, and calcium nitrate tetrahydrate as a calcium source. The mesoporous bioglass material was obtained by a template method combined with a sol-gel preparation process.

3. The method for synthesizing a mesoporous bioglass material according to claim 2, characterized in that: The following steps are involved: (1) Mesoporous hollow bioglass microspheres were prepared using hexadecyltrimethylammonium bromide as a soft template, tetraethyl orthosilicate as a silicon source, triethyl phosphate as a phosphorus source, and calcium nitrate tetrahydrate as a calcium source, wherein the molar ratios of the template, silicon source, phosphorus source, and calcium source were (9-30):60:4:12, respectively; (2) Dissolve 2 g of hexadecyltrimethylammonium bromide in a mixed solution of 80 mL of anhydrous ethanol and 160 mL of deionized water at room temperature, stir until clear, add 3.6 mL of ammonia water, stir magnetically for 2 h, then add 2.8 g of ethyl orthosilicate, stir for 1 h, and obtain a solution with a white precipitate. (3) Add 0.4 g of triethyl phosphate, stir for 1 h until completely mixed, then add 1.2 g of calcium nitrate tetrahydrate, continue stirring for 12 h to obtain a white suspension, then filter it, wash with anhydrous ethanol and deionized water, repeat the washing 2-3 times, and dry it at 60 ° C for 24 h; (4) The obtained white powder was placed in a Muffle furnace and calcined at 550°C for 6 h at a heating rate of 2°C / min to completely remove the template, thereby obtaining a mesoporous bioglass material.

4. The method for synthesizing a mesoporous bioglass material according to claim 2, characterized in that: The hexadecyltrimethylammonium bromide is a quaternary ammonium salt organic compound, which is obtained by a quaternization method, using hexadecanol and hydrobromic acid as raw materials, firstly undergoing a bromination reaction in the presence of a sulfuric acid catalyst to generate hexadecane bromide, and then undergoing a quaternization reaction with trimethylamine; Micelle formation in solution provides a template for the formation of mesoporous structure.

5. The method for synthesizing a mesoporous bioglass material according to claim 2, characterized in that: The tetraethyl orthosilicate can be prepared by reacting silicon tetrachloride with ethanol, and is a common precursor for preparing silicon-based materials, and its hydrolysis product can form a silicon skeleton; The calcium nitrate tetrahydrate is prepared by mixing an appropriate amount of nitric acid with a calcium hydroxide solution to generate an aqueous solution of calcium nitrate, and obtaining calcium nitrate tetrahydrate crystals from the aqueous solution by evaporation and crystallization, thereby providing calcium elements for bioglass and improving its biological activity and bone bonding ability.

6. The method for synthesizing a mesoporous bioglass material according to claim 2, characterized in that: Ammonia water is added during the preparation process to adjust the pH value of the solution and maintain alkalinity to promote the hydrolysis and polycondensation reactions of the silicon source and the phosphorus source.

7. The use of a mesoporous bioglass material according to claim 1, characterized in that: The mesoporous bioglass material promotes bone mass recovery and collagen deposition and is used for bone repair in skull defects.

8. The use of a mesoporous bioglass material according to claim 7, characterized in that: The bone repair material is made of a single material of mesoporous bioglass material or a related composite material using the mesoporous bioglass material as a carrier or a filling scaffold.

Citation Information

Patent Citations

  • Biological activity glass mesoporous microsphere and preparation method thereof

    CN101314039A

  • Micro-nano rod-shaped bioactive glass and preparation method and application thereof

    CN104288830A

  • Mesoporous hollow core-shell bioactive glass drug carrier material and preparation method thereof

    CN107686247A

  • Preparation method and application of hollow mesoporous bioglass microspheres

    CN108455862A

Cited By

  • Antibacterial and anti-inflammatory regenerative pulp capping material and preparation method thereof

    CN121015962A